ReviewTargeted oncology2016

Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC).

Mario Scartozzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.